Jounce Therapeutics
0 sources
Financials
Summary
Jounce Therapeutics is a business[1].
Key Facts
- Jounce Therapeutics is in the country of United States[2].
- Jounce Therapeutics is in the country of US[3].
- Jounce Therapeutics's instance of is recorded as business[4].
- Jounce Therapeutics's instance of is recorded as public company[5].
- Jounce Therapeutics's headquarters location is recorded as Cambridge[6].
- Jounce Therapeutics's stock exchange is recorded as Nasdaq[7].
- Jounce Therapeutics's industry is recorded as pharmaceutical industry[8].
- January 1, 2013 marks the founding of Jounce Therapeutics[9].
- 2024-07-12 marks the founding of Jounce Therapeutics[10].
- Jounce Therapeutics's parent organization or unit is recorded as gleif:254900C0FTELHTMZ1C33[11].
- Jounce Therapeutics's official website is recorded as http://jouncetx.com/[12].
- Jounce Therapeutics's legal form is recorded as Delaware corporation[13].
- Jounce Therapeutics's legal form is recorded as 8WM4[14].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 5493004MZJQIV2K8ZT61[15]
-
Registered legal name: Tang Capital Partners Iii, INC.[16]
-
Legal jurisdiction: US-NV[17]
-
GLEIF entity category: GENERAL[18]
-
Legal form (ISO 20275 ELF): 8WM4[19]
-
Entity status: ACTIVE[20]
-
LEI registration status: ISSUED[21]
-
Entity created: 2024-07-12[22]
-
LEI first registered: 2015-11-26[23]
-
LEI last updated: 2026-03-19[24]
-
LEI next renewal: 2027-03-25[25]
-
Managing LOU: 5493001KJTIIGC8Y1R12[26]
-
Registration authority: RA000627[27]
-
Authority entity ID: NV20243158874[28]
-
Other names: Jounce Therapeutics, INC.[29]
-
Conformity flag: NON_CONFORMING[30]
Body
Founding
Recorded inception include January 1, 2013[9] and 2024-07-12[10].
Operations
Jounce Therapeutics's headquarters location is recorded as Cambridge[6]. Its parent organization or unit is recorded as gleif:254900C0FTELHTMZ1C33[11].
Industry
Jounce Therapeutics's industry is recorded as pharmaceutical industry[8].
Ownership
Jounce Therapeutics's stock exchange is recorded as Nasdaq[7].